Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research

In [1], the following changes to wording need to be made. On page 20, second column, first paragraph, second line, “vertebral” should be omitted from the phrase “clinical vertebral fracture.” The sentence is now corrected to read as follows. Similarly, age (as a continuous variable) and hip BMD T-score (lowest versus other two tertiles), at time of ALN discontinuation, predicted clinical fractures during the subsequent 5 years. On page 20, second column, fourth paragraph, line 9, the phrase “morphometric vertebral” should be inserted before “incident” when referring to Horizon extension. The sentence is now corrected to read as follows. Subjects who seemed to benefit most from long-term ALN or ZOL therapy are those categorized as high risk, best captured by a persistent low T-score at hip (−2.5 in HORIZON for total hip or femoral neck T-score and above −2.5 but ≤−2 for femoral neck in FLEX), or incident morphometric vertebral fracture during the core study in HORIZON. This corrigendum corrects the addition and omission.